MedTrace Logo

Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells

NCT06176105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101000

Last updated 2023-12-19

No results posted yet for this study

Summary

The MATER study is an observational cohort study on first ever transfusion recipients in six hospitals in the Netherlands, with information collected on both donor and patient characteristics. We aim to further specify which combination of characteristics of both donors and patients determine the increased risk of mortality after blood transfusions.

Conditions

Sponsors & Collaborators

  • Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research

    lead OTHER

Principal Investigators

  • J van der Bom, Prof · Jon J van Rood Center for Clinical Transfusion Research

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176105 on ClinicalTrials.gov